Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

Comparing two methods of glaucoma drainage device implantation

Official title: Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Run by University of Pennsylvania · NCT05924477 · Data updated 2026-11-12

This study is testing whether placing a glaucoma drainage device in the front part of the eye or in a different spot helps people with glaucoma manage their eye pressure and cell health better over time.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment226 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations8 sites (San Francisco, California and 7 other locations)
StatusRecruiting
StartedJuly 11, 2023
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedJuly 14, 2026
Trial IDNCT05924477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with medically uncontrolled glaucoma requiring a glaucoma drainage device.

Probably not a fit

Patients with preexisting corneal conditions or those who have undergone previous glaucoma surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The DECLARE Trial is a multi-center, randomized clinical trial designed to compare the effects of glaucoma drainage device (GDD) implantation in two different locations: the anterior chamber and the ciliary sulcus. This study aims to assess the impact of these placements on endothelial cell density and intraocular pressure over a 12-month follow-up period, with an extended follow-up of 24 months for additional outcomes. Participants will be randomly assigned to one of the two tube placement groups, ensuring balanced representation across clinical centers and surgical types. The trial employs a double-masked design to minimize bias in outcome assessment.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical techniques that minimize endothelial cell loss in glaucoma patients.

How similar studies have gone: Other studies have explored similar surgical techniques, but this specific comparison of tube placement locations is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Medically uncontrolled glaucoma requiring GDD or GDD combined with phacoemulsification as the planned surgical procedure
* Candidate for GDD implantation for ciliary sulcus and AC tube
* Age greater than or equal to 18 years old

Exclusion Criteria:

* Preexisting corneal condition that would affect the corneal endothelium or previous corneal transplant
* Presence or history of Cypass Micro-Stent
* Previous GDD, Xen Gel Stent or Preserflo MicroShunt removed less than 6 months before surgery
* Presence of GDD implantation, Xen Gel Stent, of Preserflo MicroShunt
* Previous trabeculectomy and/or minimally invasive glaucoma surgery within the past 6 months
* AC intraocular lens
* Presence of nanophthalmos, uncontrolled uveitis, silicone oil, Sturge-Weber syndrome or other conditions associated with elevated episcleral venous pressure
* Unwilling or unable to give consent, unwilling to accept randomization, or unable to return for scheduled protocol visits
* No light perception vision in the study eye or fellow eye visual acuity \< 20/200
* Need for glaucoma surgery combined with other ocular procedures (i.e. corneal transplant, or retinal surgery) or anticipated need for additional ocular surgery

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting
  • Diablo Eye Associates
    Walnut Creek, California, United States
    Recruiting
  • Bascom Palmer Eye Institute
    Miami, Florida, United States
    Recruiting
  • Wilmer Eye Institute, Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting
  • Massachusetts Eye and Ear
    Boston, Massachusetts, United States
    Recruiting
  • University of Buffalo/State University of New York
    Buffalo, New York, United States
    Recruiting
Show 2 more locations
  • University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina, United States
    Recruiting
  • Prism Eye Institute, University of Toronto
    Toronto, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.